866-997-4948(US-Canada Toll Free)

Implantable Drug-Eluting Devices Market - Global Industry Analysis and Opportunity Assessment, 2019-2029

Published By :

Future Market Insights

Published Date : Nov 2019

Category :

Healthcare

No. of Pages : 326 Pages

A recent market study published by Future Market Insights on the implantable drug-eluting devices market includes global industry analysis for 2014 - 2018 & opportunity assessment for 2019 - 2029 and delivers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical as well as current growth parameters of the implantable drug-eluting devices market, the growth prospects of the market are obtained with maximum precision.

Chapter 01 – Executive Summary

The report initiates with the executive summary of the implantable drug-eluting devices market, which includes a summary of key findings and statistics of the market. It also includes drivers and trends of the implantable drug-eluting devices market.

Chapter 02 – Market Overview

Readers can find the definition and detailed segmentation of the implantable drug-eluting devices market in this chapter. Along with, this section also highlights the inclusions and exclusions, which help the reader understand the scope of the implantable drug-eluting devices market report.

Chapter 03 – Market Trends

This section gives information about the key trends impacting the implantable drug-eluting devices market.

Chapter 04 – Key Success Factors

This section explains the key success factors of the market including new product launches and regulatory approvals and what are the key strategies followed by the manufacturers for the growth of the market.

Chapter 05 – Market Context

This section gives information about regulatory scenario, product adoption, application analysis and reimbursement scenario of the implantable drug-eluting devices market.

Chapter 6 – Global Implantable Drug-Eluting Devices Market Demand Analysis 2014-2018 and Forecast, 2018-2028

This section explains the global market volume analysis and forecast for the implantable drug-eluting devices market during the forecast periods of 2019-2029. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).

Chapter 7 – Global Implantable Drug-Eluting Devices Market Pricing Analysis

This section provides regional level pricing of the product that is manufacturer level pricing and distributor level pricing.

Chapter 8 – Global Implantable Drug-Eluting Devices Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

This section explains the global market value analysis and forecast for the implantable drug-eluting devices market during the forecast periods of 2019-2029. Along with that, it includes historical implantable drug-eluting devices market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).

Chapter 9 – Market Background

This section includes major factors influencing the market and various drivers, restraints and opportunities of the market.

Chapter 10 – Global Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029, by Technology

Based on technology, the implantable drug-eluting devices market is segmented into active drug-eluting devices and passive drug-eluting devices.

Chapter 11 – Global Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029, by Product

Based on product type, the market is segmented into implantable drug infusion pumps, intraocular drug-eluting devices, contraceptive drug-eluting devices, buprenorphine implant, drug-eluting stents and others.

Chapter 12 – Global Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029, by Application

Based on application, the market is segmented into diabetes, birth control/contraception, opioid addiction, cardiovascular, ophthalmology, oncology, pain management, and others.

Chapter 13 – Global Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029, by Implantation

Based on Implantation type, the market is segmented into intravaginal, intravascular, intraocular, intrathecal, and subcutaneous.

Chapter 14 – Global Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029, by End User

Based on end user, the market is segmented into, hospitals, ambulatory surgical centres, optical care centres, cardiac surgery centres, office-based settings, and others.

Chapter 15 – Global Implantable Drug-Eluting Devices Market Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Region

This chapter explains how the implantable drug-eluting devices market will grow across various geographic regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa (MEA).

Chapter 16 – North America Implantable Drug-Eluting Devices Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter includes a detailed analysis of the growth of the North America implantable drug-eluting devices market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on product type, application, Implantation type, end user, and countries in North America.

Chapter 17 – Latin America Implantable Drug-Eluting Devices Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides the growth scenario of the implantable drug-eluting devices market in Latin American countries such as Brazil, Mexico, Argentina and the Rest of Latin America. Along with this, an assessment of the market across target segments has been provided. 

Chapter 18 – Europe Implantable Drug-Eluting Devices Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

Important growth prospects of the implantable drug-eluting devices market based on its end-users in several countries such as the Germany, Italy, France, the U.K., Spain, Benelux, Russia and the Rest of Europe are included in this chapter.

Chapter 19 – South Asia Implantable Drug-Eluting Devices Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

Important growth prospects of the implantable drug-eluting devices market based on its end-users in several countries such as India, Thailand, Indonesia, Malaysia and the rest of South Asia are included in this chapter.

Chapter 20 – East Asia Implantable Drug-Eluting Devices Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

In this chapter, China, Japan and South Korea are the prominent countries in East Asia that are the prime subjects of assessment to obtain the growth prospects of the implantable drug-eluting devices market. Readers can find detailed information about the growth parameters of the implantable drug-eluting devices market during the forecast period of 2019-2029.

Chapter 21 – Oceania Implantable Drug-Eluting Devices Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

This section highlights the growth prospects of the implantable drug-eluting devices market for Australia and New Zealand, during the forecast period of 2019-2029.

Chapter 22 – MEA Implantable Drug-Eluting Devices Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides information about how the implantable drug-eluting devices market will grow in major countries in the MEA region such as GCC Countries, South Africa, Northern Africa, Turkey and the Rest of MEA, during the forecast period of 2019-2029.

Chapter 23 – Emerging Countries Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029

This section highlights the growth prospects of the implantable drug-eluting devices market for the emerging countries such as China, India and Brazil.

Chapter 24 – Market Structure Analysis

This chapter provides information about the market structure analysis by tier of companies. Readers can find a detailed analysis of market concentration and market presence by the regional footprint of players, product footprint by players and channel footprint by players.

Chapter 25 – Competition Analysis

In this chapter, readers can find a comprehensive list of all prominent stakeholders in the implantable drug-eluting devices market, along with detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Pfizer Inc., Medtronic Inc., Merck & Co., Inc., Bayer AG, Johnson & Johnson, Abbott, SurModics Inc., AstraZeneca Plc., Boston Scientific Corporation, Titan Pharmaceuticals, Inc., BIOTRONIK, INC., Allergan, Inc., Bausch and Lomb, Inc., Alimera Sciences, REVA Medical, Inc.

Chapter 26 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the implantable drug-eluting devices market report.

Chapter 27 – Research Methodology

This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the implantable drug-eluting devices market.

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusion & Exclusion/ Scope of the Report

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Development Trends

4. Key Success Factors

4.1. New Product Launches & Regulatory Approvals

4.2. Key Strategies Followed By Manufacturers

5. Market Context

5.1. Product Adoption / Application Analysis

5.2. Regulatory Scenario

5.3. Value Chain Analysis 

5.4. Reimbursement Scenario

6. Global Implantable Drug-Eluting Devices Market Demand Analysis 2014-2018 and Forecast, 2019-2029

6.1. Historical Market Volume (Units) Analysis, 2014-2018

6.2. Current and Future Market Volume (Units) Projections, 2018-2028

6.3. Y-o-Y Growth Trend Analysis

7. Global Implantable Drug-Eluting Devices Market Pricing Analysis

7.1. Regional Pricing Analysis By Product Type

7.2. Pricing Break-up

7.2.1. Manufacturer Level Pricing

7.2.2. Distributor Level Pricing

7.3. Global Average Pricing Analysis Benchmark

8. Global Implantable Drug-Eluting Devices Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

8.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

8.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

8.2.1. Y-o-Y Growth Trend Analysis

8.2.2. Absolute $ Opportunity Analysis

9. Market Background

9.1. Macro-Economic Factors

9.1.1. Global GDP Growth Outlook

9.1.2. Global Healthcare Outlook 

9.1.3. Per Capita Healthcare Expenditure Outlook

9.2. Forecast Factors - Relevance & Impact

9.3. Market Dynamics

9.3.1. Drivers

9.3.2. Restraints

9.3.3. Opportunity Analysis

10. Global Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029, by Technology 

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) Analysis By Technology, 2014 - 2018

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2019 – 2029

10.3.1. Active Drug-Eluting Device

10.3.2. Passive Drug-Eluting Device

10.3.2.1. Biodegradable implants

10.3.2.2. Non-biodegradable implants

10.4. Market Attractiveness Analysis By Technology 

11. Global Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014 - 2018

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019 - 2029

11.3.1. Implantable Drug Infusion Pumps

11.3.2. Intraocular Drug-Eluting Devices

11.3.3. Contraceptive Drug-Eluting Devices

11.3.4. Buprenorphine Implant

11.3.5. Drug-Eluting Stents 

11.3.6. Others

11.4. Market Attractiveness Analysis By Product Type

12. Global Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029, by Application

12.1. Introduction / Key Findings

12.2. Historical Market Size (US$ Mn) Analysis By Application, 2014 - 2018

12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2019 - 2029

12.3.1. Diabetic Macular Edema

12.3.2. Birth Control/Contraception

12.3.3. Opioid Addiction

12.3.4. Cardiovascular 

12.3.5. Ophthalmology

12.3.6. Oncology

12.3.7. Pain Management

12.4. Market Attractiveness Analysis By Application

13. Global Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029, by Implantation Type

13.1. Introduction / Key Findings

13.2. Historical Market Size (US$ Mn) Analysis By Implantation Type, 2014 - 2018

13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Implantation Type, 2019 - 2029

13.3.1. Intravaginal 

13.3.2. Intravascular

13.3.3. Intraocular

13.3.4. Intrathecal

13.3.5. Subcutaneous

13.3.6. Intrauterine

13.4. Market Attractiveness Analysis By Implantation Type

14. Global Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029, by End User

14.1. Introduction / Key Findings

14.2. Historical Market Size (US$ Mn) Analysis By End User, 2014 - 2018

14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019 - 2029

14.3.1. Hospitals

14.3.2. Ambulatory Surgical Centres

14.3.3. Optical Care Centres

14.3.4. Cardiac Surgery Centres

14.3.5. Office based settings

14.3.6. Others

14.4. Market Attractiveness Analysis By End User

15. Global Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029, by Region

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2018

15.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029

15.3.1. North America

15.3.2. Latin America

15.3.3. Europe

15.3.4. Middle East and Africa (MEA)

15.3.5. East Asia

15.3.6. South Asia

15.3.7. Oceania

15.4. Market Attractiveness Analysis By Region

16. North America Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018

16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

16.3.1. By Country

16.3.1.1. U.S.

16.3.1.2. Canada

16.3.2. By Technology

16.3.3. By Product Type

16.3.4. By Application

16.3.5. By Implantation Type

16.3.6. By End User

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Technology

16.4.3. By Product Type

16.4.4. By Application

16.4.5. By Implantation Type

16.4.6. By End User

16.5. Key Market Participants - Intensity Mapping

16.6. Drivers and Restraints - Impact Analysis

17. Latin America Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018

17.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

17.3.1. By Country

17.3.1.1. Brazil

17.3.1.2. Mexico

17.3.1.3. Rest of Latin America

17.3.2. By Technology

17.3.3. By Product Type

17.3.4. By Application

17.3.5. By Implantation Type

17.3.6. By End User

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Technology

17.4.3. By Product Type

17.4.4. By Application

17.4.5. By Implantation Type

17.4.6. By End User

17.5. Key Market Participants - Intensity Mapping

17.6. Drivers and Restraints - Impact Analysis

18. Europe Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029

18.1. Introduction

18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018

18.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

18.3.1. By Country

18.3.1.1. Germany

18.3.1.2. Italy

18.3.1.3. France

18.3.1.4. U.K.

18.3.1.5. Spain

18.3.1.6. BENELUX

18.3.1.7. Russia

18.3.1.8. Rest of Europe

18.3.2. By Technology

18.3.3. By Product Type

18.3.4. By Application

18.3.5. By Implantation Type

18.3.6. By End User

18.4. Market Attractiveness Analysis

18.4.1. By Country

18.4.2. By Technology

18.4.3. By Product Type

18.4.4. By Application

18.4.5. By Implantation Type

18.4.6. By End User

18.5. Key Market Participants - Intensity Mapping

18.6. Drivers and Restraints - Impact Analysis

19. South Asia Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029

19.1. Introduction

19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018

19.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

19.3.1. By Country

19.3.1.1. India

19.3.1.2. Thailand

19.3.1.3. Indonesia

19.3.1.4. Malaysia

19.3.1.5. Rest of South Asia

19.3.2. By Technology

19.3.3. By Product Type

19.3.4. By Application

19.3.5. By Implantation Type

19.3.6. By End User

19.4. Market Attractiveness Analysis

19.4.1. By Country

19.4.2. By Technology

19.4.3. By Product Type

19.4.4. By Application

19.4.5. By Implantation Type

19.4.6. By End User

19.5. Key Market Participants - Intensity Mapping

19.6. Drivers and Restraints - Impact Analysis

20. East Asia Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029

20.1. Introduction

20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018

20.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

20.3.1. By Country

20.3.1.1. China

20.3.1.2. Japan

20.3.1.3. South Korea

20.3.2. By Technology

20.3.3. By Product Type

20.3.4. By Application

20.3.5. By Implantation Type

20.3.6. By End User

20.4. Market Attractiveness Analysis

20.4.1. By Country

20.4.2. By Technology

20.4.3. By Product Type

20.4.4. By Application

20.4.5. By Implantation Type

20.4.6. By End User

20.5. Key Market Participants - Intensity Mapping

20.6. Drivers and Restraints - Impact Analysis

21. Oceania Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029

21.1. Introduction

21.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018

21.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

21.3.1. By Country

21.3.1.1. Australia

21.3.1.2. New Zealand

21.3.2. By Technology

21.3.3. By Product Type

21.3.4. By Application

21.3.5. By Implantation Type

21.3.6. By End User

21.4. Market Attractiveness Analysis

21.4.1. By Country

21.4.2. By Technology

21.4.3. By Product Type

21.4.4. By Application

21.4.5. By Implantation Type

21.4.6. By End User

21.5. Key Market Participants - Intensity Mapping

21.6. Drivers and Restraints - Impact Analysis

22. Middle East and Africa Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029

22.1. Introduction

22.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018

22.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

22.3.1. By Country

22.3.1.1. GCC Countries

22.3.1.2. Turkey

22.3.1.3. Northern Africa

22.3.1.4. South Africa

22.3.1.5. Rest of Middle East and Africa

22.3.2. By Technology

22.3.3. By Product Type

22.3.4. By Application

22.3.5. By Implantation Type

22.3.6. By End User

22.4. Market Attractiveness Analysis

22.4.1. By Country

22.4.2. By Technology

22.4.3. By Product Type

22.4.4. By Application

22.4.5. By Implantation Type

22.4.6. By End User

22.5. Key Market Participants - Intensity Mapping

22.6. Drivers and Restraints - Impact Analysis

23. Emerging Countries Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029

23.1. Introduction

23.1.1. Market Value Proportion Analysis, By Key Countries

23.1.2. Global Vs. Country Growth Comparison

23.2. China Implantable Drug-Eluting Devices Market Analysis

23.2.1. Introduction

23.2.2. Market Value Proportion Analysis by Market Taxonomy

23.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

23.2.3.1. By Technology

23.2.3.2. By Product Type

23.2.3.3. By Application

23.2.3.4. By Implantation Type

23.2.3.5. By End User

23.2.4. China Implantable Drug-Eluting Devices Market - Competition Landscape

23.3. India Implantable Drug-Eluting Devices Market Analysis

23.3.1. Introduction

23.3.2. Market Value Proportion Analysis by Market Taxonomy

23.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

23.3.3.1. By Technology

23.3.3.2. By Product Type

23.3.3.3. By Application

23.3.3.4. By Implantation Type

23.3.3.5. By End User

23.3.4. India Implantable Drug-Eluting Devices Market - Competition Landscape

23.4. Brazil Implantable Drug-Eluting Devices Market Analysis

23.4.1. Introduction

23.4.2. Market Value Proportion Analysis by Market Taxonomy

23.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

23.4.3.1. By Technology

23.4.3.2. By Product Type

23.4.3.3. By Application

23.4.3.4. By Implantation Type

23.4.3.5. By End User

23.4.4. Brazil Implantable Drug-Eluting Devices Market - Competition Landscape

24. Market Structure Analysis

24.1. Market Structure Analysis by Tier of Companies

24.2. Market Share Analysis

24.3. Market Concentration

24.4. Market Presence Analysis

25. Competition Analysis

25.1. Competition Dashboard

25.2. Competition Deep Dive 

25.2.1. Pfizer Inc.

25.2.1.1. Overview

25.2.1.2. Product Portfolio

25.2.1.3. Sales Footprint

25.2.1.4. Strategy Overview

25.2.2. Medtronic Inc.

25.2.2.1. Overview

25.2.2.2. Product Portfolio

25.2.2.3. Sales Footprint

25.2.2.4. Strategy Overview

25.2.3. Merck & Co., In

25.2.3.1. Overview

25.2.3.2. Product Portfolio

25.2.3.3. Sales Footprint

25.2.3.4. Strategy Overview

25.2.4. Bayer AG 

25.2.4.1. Overview

25.2.4.2. Product Portfolio

25.2.4.3. Sales Footprint

25.2.4.4. Strategy Overview

25.2.5. Johnson & Johnson

25.2.5.1. Overview

25.2.5.2. Product Portfolio

25.2.5.3. Sales Footprint

25.2.5.4. Strategy Overview

25.2.6. SurModics Inc.

25.2.6.1. Overview

25.2.6.2. Product Portfolio

25.2.6.3. Sales Footprint

25.2.6.4. Strategy Overview

25.2.7. AstraZeneca Plc.

25.2.7.1. Overview

25.2.7.2. Product Portfolio

25.2.7.3. Sales Footprint

25.2.7.4. Strategy Overview

25.2.8. Boston Scientific Corporation

25.2.8.1. Overview

25.2.8.2. Product Portfolio

25.2.8.3. Sales Footprint

25.2.8.4. Strategy Overview

25.2.9. Titan Pharmaceuticals, Inc.

25.2.9.1. Overview

25.2.9.2. Product Portfolio

25.2.9.3. Sales Footprint

25.2.9.4. Strategy Overview

25.2.10. BIOTRONIK, INC.

25.2.10.1. Overview

25.2.10.2. Product Portfolio

25.2.10.3. Sales Footprint

25.2.10.4. Strategy Overview

25.2.11. Abbott Laboratories

25.2.11.1. Overview

25.2.11.2. Product Portfolio

25.2.11.3. Sales Footprint

25.2.11.4. Strategy Overview

25.2.12. Allergan, Inc.

25.2.12.1. Overview

25.2.12.2. Product Portfolio

25.2.12.3. Sales Footprint

25.2.12.4. Strategy Overview

25.2.13. Bausch and Lomb, Inc.

25.2.13.1. Overview

25.2.13.2. Product Portfolio

25.2.13.3. Sales Footprint

25.2.13.4. Strategy Overview

25.2.14. Alimera Sciences

25.2.14.1. Overview

25.2.14.2. Product Portfolio

25.2.14.3. Sales Footprint

25.2.14.4. Strategy Overview

25.2.15. REVA Medical, Inc.

25.2.15.1. Overview

25.2.15.2. Product Portfolio

25.2.15.3. Sales Footprint

25.2.15.4. Strategy Overview

26. Assumptions and Acronyms Used

27. Research Methodology

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *